Literature DB >> 4581078

Lymphocyte anergy in patients with carcinoma.

A P Nind, R C Nairn, J M Rolland, E P Guli, E S Hughes.   

Abstract

All of 10 patients with colonic carcinoma and 5 with malignant melanoma of skin showed no sign of immunoreactivity against the cultured tumour cells by the lymphocyte populations residing within the tumours. More than half of these patients did show cytotoxic reactivity by their blood lymphocytes. Possible cytotoxic reactivity by the regional lymph node lymphocytes was also investigated in 57 tumour cases (44 colonic, 13 melanoma, and including 12 of the 15 examined for intrinsic lymphocyte activity). One third of the cases showed positive blood lymphocyte immunoreactivity, but in only 4 tumours (3 colonic) did the node lymphocytes show any cytotoxicity against the tumour cells. This state of anergy of intrinsic and regional lymphocytes is presumably acquired during the development of the cancer and would permit local tumour spread and metastasis to lymph nodes. Its cause has not been identified but appears to be lymphocyte inhibition rather than selective change in lymphocyte population. In particular, no special pattern can be seen in the relative proportions of T and B cells in patients' blood, lymph node or intrinsic carcinoma lymphocytes.

Entities:  

Mesh:

Year:  1973        PMID: 4581078      PMCID: PMC2008880          DOI: 10.1038/bjc.1973.128

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

1.  Anti-tumor immunoreactivity in patients with malignant melanoma.

Authors:  R C Nairn; A P Nind; E P Guli; D J Davies; J H Little; N C Davis; R H Whitehead
Journal:  Med J Aust       Date:  1972-02-26       Impact factor: 7.738

2.  Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumor immunity.

Authors:  I Hellström; K E Hellström; H O Sjögren; G A Warner
Journal:  Int J Cancer       Date:  1971-09-15       Impact factor: 7.396

3.  Immunoglobulins on the surface of human lymphocytes.

Authors:  M Papamichail; J C Brown; E J Holborow
Journal:  Lancet       Date:  1971-10-16       Impact factor: 79.321

4.  Immune response to Gross virus-induced lymphoma. 3. Characteristics of the cellular immune response.

Authors:  M O De Landazuri; R B Herberman
Journal:  J Natl Cancer Inst       Date:  1972-07       Impact factor: 13.506

5.  The separation of different cell classes from lymphoid organs. 1. The use of glass bead columns to separate small lymphocytes, remove damaged cells and fractionate cell suspensions.

Authors:  K Shortman
Journal:  Aust J Exp Biol Med Sci       Date:  1966-06

6.  Prospects for immunotherapy of cancer: experience in experimental systems.

Authors:  P Alexander
Journal:  Br Med J       Date:  1970-11-21

7.  Elution of "blocking factors" from human tumors, capable of abrogating tumor-cell destruction by specifically immune lymphocytes.

Authors:  H O Sjögren; I Hellström; S C Bansal; G A Warner; K E Hellström
Journal:  Int J Cancer       Date:  1972-03-15       Impact factor: 7.396

8.  Immunological reactivity in patients with carcinoma of colon.

Authors:  R C Nairn; A P Nind; E P Guli; D J Davies; J M Rolland; A R McGiven; E S Hughes
Journal:  Br Med J       Date:  1971-12-18

9.  Tumor immunity in vitro: destruction of a mouse ascites tumor through a cycling pathway.

Authors:  G Berke; K A Sullivan; D B Amos
Journal:  Science       Date:  1972-08-04       Impact factor: 47.728

10.  Possible host resistance in carcinoma of the breast: a histological study.

Authors:  I M Hamlin
Journal:  Br J Cancer       Date:  1968-09       Impact factor: 7.640

View more
  19 in total

1.  Preparation of lymphoid cells from small specimens of human gastrointestinal mucosa.

Authors:  R W Crofton; C Cochrane; D B McClelland
Journal:  Gut       Date:  1978-10       Impact factor: 23.059

Review 2.  [The immunology of malignant melanoma (author's transl)].

Authors:  G Schieferstein
Journal:  Klin Wochenschr       Date:  1978-03-15

3.  Surface markers of small lymphocytes appearing in the mouse Ehrlich ascites tumour, host spleen and blood.

Authors:  S Garnis; P K Lala
Journal:  Immunology       Date:  1978-03       Impact factor: 7.397

4.  [The electrophoretic-mobility-(EM) test: a method for discrimination of malignant and non-malignant tumors (author's transl)].

Authors:  C Tautz; W Schneider; E Laier; G Brügmann
Journal:  Klin Wochenschr       Date:  1978-02-15

5.  Can neutrophil-to-lymphocyte ratio predict the survival of colorectal cancer patients who have received curative surgery electively?

Authors:  Sum-Fu Chiang; Hsin-Yuan Hung; Reiping Tang; Chung Rong Changchien; Jinn-Shiun Chen; Yau-Tong You; Jy-Ming Chiang; Jr-Rung Lin
Journal:  Int J Colorectal Dis       Date:  2012-03-31       Impact factor: 2.571

6.  Anti-tumor effects of the oral administration of the streptococcal preparation OK-432 (PICIBANIL)--the inhibition of carcinogenesis and growth in rats with ENNG-induced gastrointestinal tumors.

Authors:  M Takeshita; F Makita; I Takeyoshi; H Ishikawa; S Nakamura; S Owada; Y Miyamoto; M Izuo; S Kurashige
Journal:  Jpn J Surg       Date:  1990-05

7.  Role of autologous lymphocyte cytotoxicity in colonic neoplasia.

Authors:  P Gallagher; B M Vose; M Moore; P F Schofield
Journal:  Gut       Date:  1982-01       Impact factor: 23.059

8.  Immunosuppresive effect of a human hepatic glycoferroprotein, alpha2H globulin. A study on the transformation of normal human lymphocytes.

Authors:  D Buffe; C Rimbaut
Journal:  Immunology       Date:  1975-07       Impact factor: 7.397

Review 9.  Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review.

Authors:  J C Underwood
Journal:  Br J Cancer       Date:  1974-12       Impact factor: 7.640

10.  Immune response to a syngeneic rat tumour: development of regional node lymphocyte anergy.

Authors:  G R Flannery; P J Chalmers; J M Rolland; R C Nairn
Journal:  Br J Cancer       Date:  1973-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.